$8.00
16.84% yesterday
Nasdaq, Sep 03, 10:17 pm CET
ISIN
SG9999014716
Symbol
WVE

Wave Life Sciences Ltd. Target price 2025 - Analyst rating & recommendation

Wave Life Sciences Ltd. Classifications & Recommendation:

Buy
89%
Hold
11%

Wave Life Sciences Ltd. Price Target

Target Price $20.40
Price $8.00
Potential
Number of Estimates 16
16 Analysts have issued a price target Wave Life Sciences Ltd. 2026 . The average Wave Life Sciences Ltd. target price is $20.40. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 19 analysts: 17 Analysts recommend Wave Life Sciences Ltd. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Wave Life Sciences Ltd. stock has an average upside potential 2026 of . Most analysts recommend the Wave Life Sciences Ltd. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 108.30 49.42
4.42% 54.37%
EBITDA Margin -93.94% -389.95%
81.06% 315.09%
Net Margin -89.58% -362.95%
76.49% 305.19%

15 Analysts have issued a sales forecast Wave Life Sciences Ltd. 2025 . The average Wave Life Sciences Ltd. sales estimate is

$49.4m
Unlock
. This is
47.40% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$89.3m 5.00%
Unlock
, the lowest is
$17.5m 81.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $108m 4.42%
2025
$49.4m 54.37%
Unlock
2026
$54.4m 10.02%
Unlock
2027
$142m 160.53%
Unlock
2028
$219m 54.61%
Unlock
2029
$321m 46.60%
Unlock
2030
$520m 61.81%
Unlock
2031
$708m 36.20%
Unlock
2032
$934m 31.99%
Unlock

3 Analysts have issued an Wave Life Sciences Ltd. EBITDA forecast 2025. The average Wave Life Sciences Ltd. EBITDA estimate is

$-193m
Unlock
. This is
45.41% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-199m 50.22%
Unlock
, the lowest is
$-188m 41.98%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-102m 73.06%
2025
$-193m 89.42%
Unlock
2026
$-196m 1.67%
Unlock
2027
$-245m 25.08%
Unlock

EBITDA Margin

2024 -93.94% 81.06%
2025
-389.95% 315.09%
Unlock
2026
-360.36% 7.59%
Unlock
2027
-173.00% 51.99%
Unlock

15 Wave Life Sciences Ltd. Analysts have issued a net profit forecast 2025. The average Wave Life Sciences Ltd. net profit estimate is

$-179m
Unlock
. This is
38.12% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-150m 15.79%
Unlock
, the lowest is
$-217m 66.81%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-97.0m 68.68%
2025
$-179m 84.90%
Unlock
2026
$-187m 4.01%
Unlock
2027
$-125m 33.17%
Unlock
2028
$-61.5m 50.67%
Unlock
2029
$46.5m 175.58%
Unlock
2030
$185m 297.14%
Unlock
2031
$300m 62.48%
Unlock
2032
$405m 35.01%
Unlock

Net Margin

2024 -89.58% 76.49%
2025
-362.95% 305.19%
Unlock
2026
-343.15% 5.46%
Unlock
2027
-88.03% 74.35%
Unlock
2028
-28.09% 68.09%
Unlock
2029
14.48% 151.55%
Unlock
2030
35.54% 145.44%
Unlock
2031
42.40% 19.30%
Unlock
2032
43.37% 2.29%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.70 -1.15
29.63% 64.29%
P/E negative
EV/Sales 26.70

15 Analysts have issued a Wave Life Sciences Ltd. forecast for earnings per share. The average Wave Life Sciences Ltd. EPS is

$-1.15
Unlock
. This is
45.57% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.97 22.78%
Unlock
, the lowest is
$-1.39 75.95%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.70 29.63%
2025
$-1.15 64.29%
Unlock
2026
$-1.20 4.35%
Unlock
2027
$-0.80 33.33%
Unlock
2028
$-0.40 50.00%
Unlock
2029
$0.30 175.00%
Unlock
2030
$1.19 296.67%
Unlock
2031
$1.93 62.18%
Unlock
2032
$2.60 34.72%
Unlock

P/E ratio

Current -10.13 2.32%
2025
-6.94 31.47%
Unlock
2026
-6.68 3.75%
Unlock
2027
-9.99 49.55%
Unlock
2028
-20.25 102.70%
Unlock
2029
26.79 232.30%
Unlock
2030
6.75 74.80%
Unlock
2031
4.15 38.52%
Unlock
2032
3.07 26.02%
Unlock

Based on analysts' sales estimates for 2025, the Wave Life Sciences Ltd. stock is valued at an EV/Sales of

26.70
Unlock
and an P/S ratio of
30.91
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 14.04 175.83%
2025
26.70 90.14%
Unlock
2026
24.26 9.10%
Unlock
2027
9.31 61.62%
Unlock
2028
6.02 35.32%
Unlock
2029
4.11 31.79%
Unlock
2030
2.54 38.20%
Unlock
2031
1.86 26.58%
Unlock
2032
1.41 24.24%
Unlock

P/S ratio

Current 16.26 150.96%
2025
30.91 90.11%
Unlock
2026
28.10 9.10%
Unlock
2027
10.79 61.62%
Unlock
2028
6.98 35.32%
Unlock
2029
4.76 31.79%
Unlock
2030
2.94 38.20%
Unlock
2031
2.16 26.58%
Unlock
2032
1.64 24.24%
Unlock

Current Wave Life Sciences Ltd. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
Locked
Locked Aug 04 2025
Wells Fargo
Locked
Locked
Locked Jul 31 2025
Oppenheimer
Locked
Locked
Locked Jul 28 2025
Citigroup
Locked
Locked
Locked Jul 16 2025
Wedbush
Locked
Locked
Locked Jun 23 2025
Cantor Fitzgerald
Locked
Locked
Locked Apr 29 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 26 2025
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
Locked
Aug 04 2025
Locked
Wells Fargo:
Locked
Locked
Jul 31 2025
Locked
Oppenheimer:
Locked
Locked
Jul 28 2025
Locked
Citigroup:
Locked
Locked
Jul 16 2025
Locked
Wedbush:
Locked
Locked
Jun 23 2025
Locked
Cantor Fitzgerald:
Locked
Locked
Apr 29 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 26 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today